V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20053439 | 20086578 | 1.7 | 86.1 | Adjuvant (A) | 2018-03-22 | 2018-04-01 | FOXFIRE TRIAL | 02 | N | CARBOPLATIN + FLUOROURACIL | 100373402 |
| 20053455 | 20086579 | 1.6 | 56.5 | null | 2016-05-09 | 2016-05-10 | Capecitabine+Cisplatin+Streptozocin | 02 | Y | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 101530231 |
| 20053479 | 20086580 | 0 | 96.85 | Curative (C) | 2019-11-06 | 2019-11-06 | NEO-AEGIS TRIAL | 02 | N | AZACITIDINE | 100946062 |
| 20053480 | 20086581 | 0 | 15.4 | Palliative (P) | 2017-02-05 | 2017-02-05 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | SCOPE2 TRIAL | 101547005 |
| 20053543 | 20086582 | 1.57 | 62.3 | Palliative (P) | 2016-06-22 | 2016-06-27 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | HYDROXYCARBAMIDE | 100256750 |
| 20053660 | 20086584 | 1.78 | 76 | 03 | 2016-09-28 | 2016-10-03 | null | 02 | N | GEMCARBO | 100118249 |
| 20053678 | 20086585 | 1.8 | 105 | Adjuvant (A) | 2017-05-14 | 2017-05-20 | CAP + RT | 02 | N | ECARBOX | 100775772 |
| 20053721 | 20086586 | null | 56.8 | Palliative (P) | 2021-05-27 | 2021-05-28 | Doxorubicin 75mg/m2 | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101070189 |
| 20053756 | 20086587 | 1.69 | 62 | Adjuvant (A) | 2018-12-03 | 2018-12-22 | Hepatoblastoma SR Cisplatin | 01 | Y | DOXORUBICIN | 101695882 |
| 20053762 | 20086588 | 1.49 | 66 | Palliative (P) | 2019-08-26 | 2019-08-26 | Doxorubicin 75mg/m2 | 02 | N | CAP + RT | 100201248 |
| 20053770 | 20086589 | 1.75 | 63.4 | Palliative (P) | 2019-07-19 | 2019-07-19 | OXALIPLATIN | 02 | N | EVEROLIMUS | 100540315 |
| 20053777 | 20086590 | 1.57 | 70 | 03 | 2018-01-13 | 2018-02-05 | Azacitidine | N | N | CAPITAL TRIAL | 101816944 |
| 20053781 | 20086591 | 1.63 | 55.1 | null | 2017-11-15 | 2017-11-16 | EEF or EOF | 02 | N | CISPLATIN + FLUOROURACIL + RT | 101154384 |
| 20053789 | 20086592 | null | 68 | null | 2016-12-13 | 2017-01-01 | Bortezomib +/- Dexamethasone | N | Y | PACLITAXEL | 101293450 |
| 20053795 | 20086593 | 1.58 | 111.7 | 03 | 2018-05-14 | 2018-06-02 | EC | N | N | ALECTINIB | 100878887 |
| 20053815 | 20086594 | 1.93 | 113 | Neo-adjuvant (N) | 2017-09-30 | 2017-10-16 | CAPECITABINE + CETUXIMAB + IRINOTECAN | N | N | ARISTOTLE TRIAL | 101748506 |
| 20053857 | 20086595 | 1.68 | 55.8 | 03 | 2019-01-11 | 2019-01-15 | CARBOPLATIN + VINORELBINE | 1 | N | BALLAD TRIAL | 100229071 |
| 20053859 | 20086596 | 1.63 | 51.15 | Neo-adjuvant (N) | 2019-03-10 | 2019-03-30 | ARISTOTLE TRIAL | 02 | N | PACLITAXEL | 101407664 |
| 20053864 | 20086597 | 1.81 | null | Adjuvant (A) | null | 2017-02-03 | IDARUBICIN + TRETINOIN | 2 | N | IRINOTECAN | 101405162 |
| 20053874 | 20086598 | 1.6 | 60 | Palliative (P) | 2019-12-08 | 2019-12-23 | EEF or EOF | 01 | N | NIVOLUMAB | 101054045 |
| 20053875 | 20086599 | 1.56 | 119.5 | null | 2020-01-18 | 2020-01-19 | IBRUTINIB | 02 | N | CHOP R | 101456263 |
| 20053888 | 20086600 | 1.68 | 64 | Curative (C) | 2017-09-16 | 2017-09-24 | Bortezomib (weekly) | 02 | N | CISPLATIN + FLUOROURACIL + RT | 101502057 |
| 20053970 | 20086601 | 1.56 | 65 | 03 | 2018-03-07 | 2018-03-16 | ECarboX | 01 | N | ECARBOX | 100853643 |
| 20053979 | 20086602 | 1.68 | 82.3 | Palliative (P) | 2018-10-19 | 2018-11-04 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | ACTICCA-1 TRIAL | 100130246 |
| 20054125 | 20086605 | 1.55 | 65.95 | Palliative (P) | 2021-04-14 | 2021-04-26 | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 01 | N | CARBOPLATIN + FLUOROURACIL | 100557114 |
| 20054186 | 20086606 | 1.52 | 56.5 | Palliative (P) | 2018-04-11 | 2018-04-17 | ESPAC-4 TRIAL | 2 | N | HYDROXYCARBAMIDE | 101832655 |
| 20054196 | 20086607 | 1.7 | 52.2 | Adjuvant (A) | 2019-12-01 | 2019-12-14 | MCX | 02 | N | LENALIDOMIDE | 101023326 |
| 20054233 | 20086608 | 1.53 | 83.6 | Palliative (P) | 2018-04-15 | 2018-04-18 | ACTICCA-1 Trial | 02 | N | RALTITREXED | 100137113 |
| 20054349 | 20086609 | 1.53 | 102 | null | 2018-02-20 | 2018-03-03 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | 02 | N | DOCETAXEL | 101573454 |
| 20054384 | 20086610 | 1.56 | 97.9 | Palliative (P) | 2018-04-19 | 2018-05-04 | CARBOPLATIN + FLUOROURACIL | 02 | N | PACLITAXEL | 101833487 |
| 20054420 | 20086611 | 0 | 0 | Adjuvant (A) | 2016-04-19 | 2016-05-05 | Chlorambucil + Pred + Rituximab | N | null | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 100847697 |
| 20054447 | 20086612 | 1.85 | 40.4 | 03 | 2017-12-24 | 2017-12-24 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 02 | N | CAPECITABINE + STREPTOZOCIN | 100003695 |
| 20054452 | 20086613 | 1.69 | 70 | 03 | 2017-02-06 | 2017-03-23 | Erlotinib | 01 | N | CAPECITABINE + CETUXIMAB + OXALIPLATIN | 101007015 |
| 20054453 | 20086614 | 1.75 | 78.8 | Palliative (P) | 2019-10-16 | 2019-10-24 | Cisplatin+Fluorouracil+Streptozoc | 02 | Y | CARBO + FLUOROURACIL | 101333145 |
| 20054477 | 20086615 | 1.7 | 71.5 | Palliative (P) | 2019-09-11 | 2019-09-12 | FCarboSt | N | N | ACELARATE TRIAL | 101052019 |
| 20054512 | 20086616 | 1.76 | 65 | Palliative (P) | 2019-10-12 | 2019-10-26 | CARBOPLATIN + GEMCITABINE | 01 | N | FOXTROT TRIAL | 100894248 |
| 20054515 | 20086617 | 1.7 | 73.4 | Palliative (P) | 2016-10-07 | 2016-10-11 | ECarboX | 02 | N | CARBO + FLUOROURACIL | 100772634 |
| 20054521 | 20086618 | 1.71 | 85.6 | Palliative (P) | 2016-11-30 | 2016-12-05 | FOXTROT TRIAL | 01 | N | RALTITREXED | 101362876 |
| 20054581 | 20086619 | 1.53 | 87 | Palliative (P) | 2018-10-08 | 2018-10-31 | Fluorouracil + Folinic + RT Bossett | N | Y | BUSULPHAN | 100582698 |
| 20054625 | 20086620 | 1.69 | 47.6 | Adjuvant (A) | 2019-04-17 | 2019-05-02 | STREPTOZOCIN | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100394413 |
| 20054660 | 20086621 | 1.56 | 73.8 | Palliative (P) | null | 2019-05-05 | Panitumumab | N | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100658755 |
| 20054673 | 20086622 | 1.69 | 91.1 | 03 | 2019-11-18 | 2019-12-23 | Irinotecan | 02 | N | CARBOPLATIN + PEMETREXED | 101048247 |
| 20054805 | 20086623 | 1.69 | 62 | Palliative (P) | 2017-01-01 | 2017-01-09 | Pentostatin | 02 | N | RALTITREXED | 100528367 |
| 20054829 | 20086624 | 1.61 | 57 | Palliative (P) | null | 2017-03-05 | SCOPE 2 TRIAL | 02 | N | STREPTOZOCIN | 100945650 |
| 20054943 | 20086625 | 1.54 | 79.4 | Palliative (P) | 2018-01-02 | 2018-01-03 | POMALIDOMIDE | 02 | N | CABAZITAXEL | 101291072 |
| 20054968 | 20086626 | 1.7 | 76.6 | null | 2016-06-06 | 2016-06-06 | CHOP R - 21 days | 02 | N | EOF | 101687722 |
| 20054994 | 20086628 | 1.6 | 41.8 | Palliative (P) | 2016-03-26 | 2016-04-08 | LENALIDOMIDE | 02 | N | ACTICCA-1 TRIAL | 100579414 |
| 20055111 | 20086629 | 1.7 | 94.8 | 03 | 2020-01-12 | 2020-01-24 | IBRUTINIB | 02 | N | RALTITREXED | 101696605 |
| 20055187 | 20086630 | 1.9 | 70.3 | null | 2017-05-30 | 2017-06-14 | EOF | 02 | Y | RIBOCICLIB | 100319976 |
| 20055218 | 20086631 | 1.82 | 84.8 | 03 | 2016-08-22 | 2016-09-16 | LENALIDOMIDE | null | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101350650 |